Evaluation of the first potent and highly selective inhibitor of ATR kinase: An approach to selectively sensitize cancer cells to ionizing radiation and hypoxia

被引：0
|
作者：
McKenna, Gillies [1 ]
Brunner, Thomas [1 ]
Charlton, Peter [2 ]
Fokas, Emmanouil [1 ]
Hammond, Ester [1 ]
Mangan, Matthew [2 ]
Olcina, Monica [1 ]
Pires, Isabel [1 ]
Pollard, John [2 ]
Prevo, Remko [1 ]
Reaper, Philip [2 ]
机构：
[1] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England
[2] Vertex Pharmaceut Europe Ltd, Abingdon, Oxon, England
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5501
引用
收藏
页数：1
相关论文
共 48 条
  • [1] Evaluation of the first potent and highly selective inhibitor of ATR kinase: An approach to selectively sensitize cancer cells to genotoxic drugs
    Pollard, John R.
    Caron, Paul
    Charlton, Peter
    Charrier, Jean-Damien
    Golecl, Julian
    Griffithsl, Matthew
    Hall, Amy
    Hare, Brian
    Long, Joanna
    MacCormickl, Somhairle
    Milton, Sean
    Murcko, Mark
    Murphy, Cheryl
    Peek, Adele
    Reaperl, Philip
    Takemoto, Darin
    CANCER RESEARCH, 2011, 71
  • [2] The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy
    Fokas, E.
    Prevo, R.
    Reaper, P.
    Charlton, P.
    Pollard, J.
    McKenna, W. G.
    Muschel, R.
    Brunner, T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 115 - 116
  • [3] Hypoxia-Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively Eradicates Treatment-Resistant Cancer Cells
    Barnieh, Francis M.
    Morais, Goreti Ribeiro
    Loadman, Paul M.
    Falconer, Robert A.
    El-Khamisy, Sherif F.
    ADVANCED SCIENCE, 2024, 11 (34)
  • [4] BCR-Abl Silencing by siRNA: A Potent Approach to Sensitize Chronic Myeloid Leukemia Cells to Tyrosine Kinase Inhibitor Therapy
    Remant, K. C.
    Thapa, Bindu
    Ubeda, Anyeld
    Jiang, Xiaoyan
    Uludag, Hasan
    STEM CELLS AND DEVELOPMENT, 2019, 28 (11) : 734 - 744
  • [5] Discovery and characterization of the first highly potent and selective AXL receptor tyrosine kinase inhibitor AB801
    Miles, Dillon H.
    Foley, Corinne N.
    Qu, Shiwei
    Miles, Dillon H.
    Paladugu, Srinivas
    Sharif, Ehesan U.
    Thomas, Joice
    Nareddy, Pradeep
    Zhao, Guiling
    Grange, Rebecca
    Leleti, Manmohan R.
    Powers, Jay P.
    Garrido-Shaqfeh, Stefan
    Chen, Ada
    Singh, Hema
    Lee, Yue Tong
    Zhao, Xiaoning
    Green, David
    Huang, Hsin-Ting
    Jin, Lixia
    Leslie, Jhansi
    Chinn, Logan
    Paprcka, Susan L.
    Fernandez-Salas, Ester
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (12)
  • [6] ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
    Fokas, E.
    Prevo, R.
    Pollard, J. R.
    Reaper, P. M.
    Charlton, P.
    Cornelissen, B.
    Vallis, K.
    Hammond, E. M.
    Olcina, M. M.
    McKenna, W. G.
    Muschel, R. J.
    Brunner, T. B.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 41 - 41
  • [7] Design, synthesis and biological evaluation of new potent and highly selective ROS1-tyrosine kinase inhibitor
    Park, Byung Sun
    El-Deeb, Ibrahim M.
    Yoo, Kyung Ho
    Oh, Chang-Hyun
    Cho, Seung Joo
    Han, Dong Keun
    Lee, Hye-Seung
    Lee, Jae Yeol
    Lee, So Ha
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4720 - 4723
  • [8] Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation
    Kaplan, Alanna R.
    Ha Pham
    Liu, Yanfeng
    Oyaghire, Stanley
    Bahal, Raman
    Engelman, Donald M.
    Glazer, Peter M.
    MOLECULAR CANCER RESEARCH, 2020, 18 (06) : 873 - 882
  • [9] Selective vulnerability of ARID1A deficient colon cancer cells to combined radiation and ATR-inhibitor therapy
    Xu, Shan
    Sak, Ali
    Niedermaier, Ben
    Erol, Yasin Bahadir
    Groneberg, Michael
    Mladenov, Emil
    Kang, MingWei
    Iliakis, George
    Stuschke, Martin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] A Potent Autophagy Inhibitor (Lys05) Enhances the Impact of Ionizing Radiation on Human Lung Cancer Cells H1299
    Cechakova, Lucie
    Ondrej, Martin
    Pavlik, Vojtech
    Jost, Petr
    Cizkova, Dana
    Bezrouk, Ales
    Pejchal, Jaroslav
    Amaravadi, Ravi K.
    Winkler, Jeffrey D.
    Tichy, Ales
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (23)
12345